When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CTDH - Cyclo Therapeutics up 7% on positive early-stage data on Trappsol Cyclo
Ctd Holdings Inc
Thinly traded nano cap Cyclo Therapeutics (OTCQB:CTDH+7%) is up, albeit on modest turnover of 43K shares, in reaction to positive safety data from a Phase 1 clinical trial evaluating lead candidate Trappsol Cyclo in patients with Niemann-Pick Disease Type C1, a rare (1 in 100K births) inherited disorder caused by the body's inability to metabolize fats.
More news on: Cyclo Therapeutics, Inc., Healthcare stocks news, Stocks on the move,